GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alteogen Inc (XKRX:196170) » Definitions » Cyclically Adjusted PB Ratio

Alteogen (XKRX:196170) Cyclically Adjusted PB Ratio : 162.57 (As of May. 09, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Alteogen Cyclically Adjusted PB Ratio?

As of today (2025-05-09), Alteogen's current share price is ₩352500.00. Alteogen's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was ₩2,168.25. Alteogen's Cyclically Adjusted PB Ratio for today is 162.57.

The historical rank and industry rank for Alteogen's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:196170' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 29.49   Med: 138.43   Max: 212.12
Current: 164.42

During the past years, Alteogen's highest Cyclically Adjusted PB Ratio was 212.12. The lowest was 29.49. And the median was 138.43.

XKRX:196170's Cyclically Adjusted PB Ratio is ranked worse than
100% of 668 companies
in the Biotechnology industry
Industry Median: 1.47 vs XKRX:196170: 164.42

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Alteogen's adjusted book value per share data for the three months ended in Dec. 2024 was ₩5,133.562. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩2,168.25 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alteogen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Alteogen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alteogen Cyclically Adjusted PB Ratio Chart

Alteogen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 51.18 142.74

Alteogen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.18 99.78 139.18 158.55 142.74

Competitive Comparison of Alteogen's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Alteogen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alteogen's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alteogen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alteogen's Cyclically Adjusted PB Ratio falls into.


;
;

Alteogen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Alteogen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=352500.00/2168.25
=162.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alteogen's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Alteogen's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=5133.562/121.1352*121.1352
=5,133.562

Current CPI (Dec. 2024) = 121.1352.

Alteogen Quarterly Data

Book Value per Share CPI Adj_Book
201503 887.209 99.721 1,077.733
201506 876.026 100.051 1,060.638
201509 883.612 100.111 1,069.181
201512 906.737 100.220 1,095.962
201603 894.869 100.561 1,077.955
201606 883.126 100.791 1,061.384
201609 1,045.090 101.461 1,247.740
201612 1,009.502 101.561 1,204.063
201703 1,021.551 102.851 1,203.161
201706 981.847 102.611 1,159.095
201709 959.318 103.491 1,122.878
201712 877.702 102.991 1,032.331
201803 855.618 104.101 995.626
201806 827.312 104.130 962.415
201809 786.496 105.651 901.769
201812 1,451.805 104.351 1,685.324
201903 1,415.620 104.491 1,641.113
201906 1,294.438 104.881 1,495.048
201909 1,286.662 105.200 1,481.555
201912 1,398.866 105.121 1,611.966
202003 1,454.309 105.354 1,672.150
202006 1,534.064 105.112 1,767.919
202009 1,628.766 106.198 1,857.866
202012 1,211.648 105.765 1,387.724
202103 4,441.459 107.357 5,011.467
202106 3,487.370 107.579 3,926.834
202109 3,352.899 108.759 3,734.434
202112 2,639.105 109.676 2,914.834
202203 3,150.287 111.848 3,411.868
202206 3,071.126 114.072 3,261.278
202209 2,967.792 114.715 3,133.881
202212 2,880.096 115.179 3,029.028
202303 2,732.277 116.507 2,840.806
202306 3,238.750 117.182 3,348.008
202309 3,106.403 118.964 3,163.108
202312 2,795.242 118.837 2,849.297
202403 3,197.284 120.123 3,224.220
202406 3,496.120 120.007 3,528.979
202409 3,338.272 120.861 3,345.840
202412 5,133.562 121.135 5,133.562

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alteogen  (XKRX:196170) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Alteogen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Alteogen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alteogen Business Description

Industry
Traded in Other Exchanges
N/A
Address
62, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon, KOR, 34054
Alteogen Inc Inc is engaged in the development and manufacture of next-generation biopharmaceuticals using NexP Fusion Technology. It also develops & markets biobetters and biosimilars by partnerships with pharmaceutical companies. It focuses on the areas such as biobetters, a proprietary antibody-drug conjugate, and antibody biosimilars with complexity.

Alteogen Headlines

No Headlines